Osteoporosis Kit
Non-Invasive Osteoporosis & Osteopenia Detection
Detecting bone fragility earlier – safely, simply, and more accessibly.
Intro Section (Problem)
Osteoporosis and osteopenia affect millions of people worldwide, often remaining silent until a fracture occurs. Traditional detection methods can be:
- Limited in accessibility
- Dependent on specialised imaging equipment
- Involving exposure to ionising radiation
- Underused in primary care and community settings
As a result, many at-risk individuals are never tested until it’s too late.
Fryan is developing a novel, non-invasive bone health detection platform designed to make screening:
- Safer and more comfortable
- More accessible in clinical and community settings
Easier to integrate into routine health checks
Our Novel Solution
Our platform aims to detect early changes in bone quality and density using advanced, non-invasive measurement techniques, without exposing patients to radiation.
Key characteristics:
- Non-Invasive & Radiation-Free
Designed to avoid ionising radiation and invasive procedures. - Accessible & Scalable
Suitable for use in hospitals, clinics, primary care and potentially mobile screening environments. - Fast & User-Friendly
Short measurement times and a streamlined workflow. - Data-Rich
Capable of generating detailed bone health data to support earlier, more personalised interventions. - Cost-Efficient – Supports broader population-level screening and monitoring
Benefits
For Patients:
- Earlier Detection, Better Prevention
Identifying osteoporosis and osteopenia before fractures occur supports earlier lifestyle, nutritional and pharmacological interventions. - Improved Patient Experience
A comfortable, non-invasive procedure encourages more people to get screened – especially those reluctant to undergo traditional imaging. Reduced anxiety around radiation exposure - Data-Driven Insights
Integrated analytics (e.g. AI-based risk stratification) can support more personalised and targeted treatment plan
For Clinicians & Health Systems:
- Supports risk stratification and targeted treatment
- Enables population-level screening programmes
- Potential to reduce fracture-related costs and admissions
Target Markets and Applications
- Hospitals, clinics and imaging centres
- Primary care and community health settings
- Preventive health check-up centres
- Occupational health and corporate wellness programmes
- Emerging markets where access to existing imaging infrastructure is limited
Development & Commercialisation Pathway
Fryan is progressing this platform through:
- Technology optimisation and validation
- Clinical validation in collaboration with leading centres
- Regulatory approvals in key markets
- Integration with electronic health records and digital health platforms
- Strategic partnerships with healthcare providers and device manufacturers
We welcome investment and clinical collaboration to accelerate this technology from development into widespread clinical use.